Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India--the HIVIND study protocol.

De Costa A, Shet A, Kumarasamy N, Ashorn P, Eriksson B, Bogg L, Diwan VK; HIVIND study team.

BMC Med Res Methodol. 2010 Mar 26;10:25. doi: 10.1186/1471-2288-10-25.

2.

Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India.

Shet A, De Costa A, Kumarasamy N, Rodrigues R, Rewari BB, Ashorn P, Eriksson B, Diwan V; HIVIND Study Team.

BMJ. 2014 Oct 24;349:g5978. doi: 10.1136/bmj.g5978.

3.

Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India.

Rodrigues R, Shet A, Antony J, Sidney K, Arumugam K, Krishnamurthy S, D'Souza G, DeCosta A.

PLoS One. 2012;7(8):e40723. doi: 10.1371/journal.pone.0040723. Epub 2012 Aug 27.

4.

Mobile phones to support adherence to antiretroviral therapy: what would it cost the Indian National AIDS Control Programme?

Rodrigues R, Bogg L, Shet A, Kumar DS, De Costa A.

J Int AIDS Soc. 2014 Sep 2;17:19036. doi: 10.7448/IAS.17.1.19036. eCollection 2014.

5.

'The phone reminder is important, but will others get to know about my illness?' Patient perceptions of an mHealth antiretroviral treatment support intervention in the HIVIND trial in South India.

Rodrigues R, Poongulali S, Balaji K, Atkins S, Ashorn P, De Costa A.

BMJ Open. 2015 Nov 2;5(11):e007574. doi: 10.1136/bmjopen-2015-007574.

6.

Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders.

Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, MacKeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR.

AIDS. 2011 Mar 27;25(6):825-34. doi: 10.1097/QAD.0b013e32834380c1.

7.
8.

Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India.

Shet A, Arumugam K, Rodrigues R, Rajagopalan N, Shubha K, Raj T, D'souza G, De Costa A.

AIDS Behav. 2010 Jun;14(3):716-20. doi: 10.1007/s10461-009-9658-3.

PMID:
20054634
9.

Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial.

Bigna JJ, Noubiap JJ, Kouanfack C, Plottel CS, Koulla-Shiro S.

Lancet Infect Dis. 2014 Jul;14(7):600-8. doi: 10.1016/S1473-3099(14)70741-8. Epub 2014 Jun 2.

PMID:
24932893
10.

The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy.

Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink J, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA.

Trials. 2011 Jan 7;12:5. doi: 10.1186/1745-6215-12-5.

11.

Supporting patient adherence to antiretrovirals using mobile phone reminders: patient responses from South India.

Sidney K, Antony J, Rodrigues R, Arumugam K, Krishnamurthy S, D'souza G, De Costa A, Shet A.

AIDS Care. 2012;24(5):612-7. doi: 10.1080/09540121.2011.630357. Epub 2011 Dec 7.

PMID:
22150088
12.

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.

Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):495-502. doi: 10.1097/QAI.0000000000000770.

PMID:
26218411
13.

Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: A randomized clinical trial.

Abdulrahman SA, Rampal L, Ibrahim F, Radhakrishnan AP, Kadir Shahar H, Othman N.

PLoS One. 2017 May 16;12(5):e0177698. doi: 10.1371/journal.pone.0177698. eCollection 2017.

14.

Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders.

Kelly JD, Giordano TP.

AIDS. 2011 May 15;25(8):1137; reply 1138-9. doi: 10.1097/QAD.0b013e32834670d7. No abstract available.

PMID:
21537118
15.

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.

Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA.

Lancet. 2010 Nov 27;376(9755):1838-45. doi: 10.1016/S0140-6736(10)61997-6. Epub 2010 Nov 9.

PMID:
21071074
16.

Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring.

Armstrong AW, Watson AJ, Makredes M, Frangos JE, Kimball AB, Kvedar JC.

Arch Dermatol. 2009 Nov;145(11):1230-6. doi: 10.1001/archdermatol.2009.269.

PMID:
19917951
17.

Mobile phone messaging reminders for attendance at healthcare appointments.

Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J.

Cochrane Database Syst Rev. 2013 Dec 5;(12):CD007458. doi: 10.1002/14651858.CD007458.pub3. Review.

PMID:
24310741
18.

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.

Horvath T, Azman H, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD009756. doi: 10.1002/14651858.CD009756. Review.

PMID:
22419345
19.

The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy.

Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C.

PLoS One. 2012;7(12):e46909. doi: 10.1371/journal.pone.0046909. Epub 2012 Dec 6.

20.

A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial.

Christopoulos KA, Riley ED, Tulsky J, Carrico AW, Moskowitz JT, Wilson L, Coffin LS, Falahati V, Akerley J, Hilton JF.

BMC Infect Dis. 2014 Dec 31;14:718. doi: 10.1186/s12879-014-0718-6.

Supplemental Content

Support Center